YHB Investment Advisors Inc. Acquires 203 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

YHB Investment Advisors Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 30,824 shares of the healthcare conglomerate’s stock after buying an additional 203 shares during the quarter. UnitedHealth Group comprises 1.5% of YHB Investment Advisors Inc.’s portfolio, making the stock its 15th biggest holding. YHB Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $18,022,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth about $27,000. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Macroview Investment Management LLC raised its holdings in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. West Financial Advisors LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth about $32,000. Finally, Delos Wealth Advisors LLC raised its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.9 %

Shares of UnitedHealth Group stock opened at $564.48 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The stock has a market cap of $521.25 billion, a P/E ratio of 36.77, a P/E/G ratio of 1.67 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $584.16 and its 200-day moving average is $536.49.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the business posted $6.56 EPS. The business’s revenue was up 9.2% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wells Fargo & Company boosted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. UBS Group decreased their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.